Gilead Sciences, Inc. v. United States ex rel. Campie

Pending petition
Docket No. Op. Below Argument Opinion Vote Author Term
17-936 9th Cir. TBD TBD TBD TBD TBD

Disclosure: Goldstein & Russell, P.C., whose attorneys contribute to this blog in various capacities, is among the counsel to the respondent in this case.

Issue: Whether a False Claims Act allegation fails when the government continued to approve and to pay for products after learning of alleged regulatory infractions and the pleadings offer no basis for overcoming the strong inference of immateriality that arises from the government's response.

SCOTUSblog Coverage

DateProceedings and Orders
Dec 26 2017Petition for a writ of certiorari filed. (Response due February 2, 2018)
Jan 16 2018Blanket Consent filed by counsel for both Petitioner, Gilead Sciences, Inc. and Respondents Jeffrey Campie and Sherilyn Campie.
Jan 22 2018Motion to extend the time to file a response from February 2, 2018 to March 5, 2018, submitted to The Clerk.
Jan 26 2018Motion to extend the time to file a response is granted and the time is extended to and including March 5, 2018.
Feb 01 2018Brief amici curiae of Chamber of Commerce for the United States of America, et al. filed.
Feb 02 2018Brief amicus curiae of Coalition for Government Procurement filed.
Feb 02 2018Brief amici curiae of Pharmaceutical Research and Manufacturers of America; Biotechnology Innovation Organization filed.
Feb 02 2018Brief amicus curiae of Washington Legal Foundation filed.
Feb 02 2018Brief amicus curiae of CTIA - The Wireless Association filed.
Feb 02 2018Brief amicus curiae of ConocoPhillips Company filed.
 
Share:
Term Snapshot
Awards